List of Tables
Table 1. Respiratory Syncytial Virus Diagnostic Testing Market Trends
Table 2. Respiratory Syncytial Virus Diagnostic Testing Market Drivers & Opportunity
Table 3. Respiratory Syncytial Virus Diagnostic Testing Market Challenges
Table 4. Respiratory Syncytial Virus Diagnostic Testing Market Restraints
Table 5. Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Respiratory Syncytial Virus Diagnostic Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Respiratory Syncytial Virus Diagnostic Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus Diagnostic Testing
Table 10. Global Respiratory Syncytial Virus Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Respiratory Syncytial Virus Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. F. Hoffmann-La Roche AG Basic Information List
Table 32. F. Hoffmann-La Roche AG Description and Business Overview
Table 33. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of F. Hoffmann-La Roche AG (2019-2024)
Table 35. F. Hoffmann-La Roche AG Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Thermo Fisher Scientific Basic Information List
Table 42. Thermo Fisher Scientific Description and Business Overview
Table 43. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Thermo Fisher Scientific (2019-2024)
Table 45. Thermo Fisher Scientific Recent Developments
Table 46. BD (Becton, Dickinson and Company) Basic Information List
Table 47. BD (Becton, Dickinson and Company) Description and Business Overview
Table 48. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of BD (Becton, Dickinson and Company) (2019-2024)
Table 50. BD (Becton, Dickinson and Company) Recent Developments
Table 51. QuidelOrtho Corporation Basic Information List
Table 52. QuidelOrtho Corporation Description and Business Overview
Table 53. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of QuidelOrtho Corporation (2019-2024)
Table 55. QuidelOrtho Corporation Recent Developments
Table 56. Hologic, Inc. Basic Information List
Table 57. Hologic, Inc. Description and Business Overview
Table 58. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Hologic, Inc. (2019-2024)
Table 60. Hologic, Inc. Recent Developments
Table 61. Luminex Corporation Basic Information List
Table 62. Luminex Corporation Description and Business Overview
Table 63. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Luminex Corporation (2019-2024)
Table 65. Luminex Corporation Recent Developments
Table 66. Agilent Technologies, Inc. Basic Information List
Table 67. Agilent Technologies, Inc. Description and Business Overview
Table 68. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Agilent Technologies, Inc. (2019-2024)
Table 70. Agilent Technologies, Inc. Recent Developments
Table 71. Cepheid (Danaher Corporation) Basic Information List
Table 72. Cepheid (Danaher Corporation) Description and Business Overview
Table 73. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of Cepheid (Danaher Corporation) (2019-2024)
Table 75. Cepheid (Danaher Corporation) Recent Developments
Table 76. DiaSorin S.p.A. Basic Information List
Table 77. DiaSorin S.p.A. Description and Business Overview
Table 78. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Respiratory Syncytial Virus Diagnostic Testing Business of DiaSorin S.p.A. (2019-2024)
Table 80. DiaSorin S.p.A. Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Respiratory Syncytial Virus Diagnostic Testing Downstream Customers
Table 84. Respiratory Syncytial Virus Diagnostic Testing Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Respiratory Syncytial Virus Diagnostic Testing Product Picture
Figure 2. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Respiratory Syncytial Virus Diagnostic Testing Report Years Considered
Figure 5. Global Respiratory Syncytial Virus Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2023
Figure 7. Respiratory Syncytial Virus Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antigen Detection Test Picture
Figure 9. Molecular Diagnostic Test Picture
Figure 10. Direct Fluorescent Antibody Test Picture
Figure 11. Diagnostic Imaging Picture
Figure 12. Others Picture
Figure 13. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Diagnostic Laboratories
Figure 17. Product Picture of Others
Figure 18. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Respiratory Syncytial Virus Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Testing Sales Value (%), (2019-2030)
Figure 31. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 37. China Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 39. China Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 49. India Respiratory Syncytial Virus Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Type (%), 2023 VS 2030
Figure 51. India Respiratory Syncytial Virus Diagnostic Testing Sales Value by Application (%), 2023 VS 2030
Figure 52. Respiratory Syncytial Virus Diagnostic Testing Industrial Chain
Figure 53. Respiratory Syncytial Virus Diagnostic Testing Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation